comparemela.com

Latest Breaking News On - Quarter for exact sciences - Page 12 : comparemela.com

Swiss National Bank Sells 63,200 Shares of Exact Sciences Co (NASDAQ:EXAS)

Swiss National Bank trimmed its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.8% during the third quarter, HoldingsChannel.com reports. The fund owned 580,280 shares of the medical research company’s stock after selling 63,200 shares during the quarter. Swiss National Bank’s holdings in Exact Sciences were worth $39,587,000 at the end of the […]

Exact Sciences Co (NASDAQ:EXAS) Shares Acquired by Artisan Partners Limited Partnership

Artisan Partners Limited Partnership boosted its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 11.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,961,514 shares of the medical research company’s stock after purchasing an additional 418,770 shares […]

Blueshift Asset Management LLC Makes New $402,000 Investment in Exact Sciences Co (NASDAQ:EXAS)

Blueshift Asset Management LLC acquired a new stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 5,887 shares of the medical research company’s stock, valued at approximately $402,000. Other […]

New York State Common Retirement Fund Sells 59,061 Shares of Exact Sciences Co (NASDAQ:EXAS)

New York State Common Retirement Fund trimmed its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 14.8% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 339,704 shares of the medical research company’s stock after selling 59,061 shares during […]

Milestone Investment Advisors LLC Invests $57,000 in Exact Sciences Co (NASDAQ:EXAS)

Milestone Investment Advisors LLC bought a new position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 842 shares of the medical research company’s stock, valued at approximately $57,000. Other hedge funds and other […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.